Back to today’s briefing

Story perspectives

Congress Invests $30B to Combat Drug Shortages Crisis

7/11/2025

41 8

Summary

Story summary

The US Congress is rallying to bolster domestic pharmaceutical production, backed by over $30 billion from industry giants like Novartis and Eli Lilly. Yet, drug shortages, especially in sterile injectables, continue to plague the system, exacerbated by dependence on single suppliers and foreign ingredients. Tariffs threaten to deepen this crisis, underscoring the urgent need for effective solutions.

1 of 1

Story summary

The US Congress is rallying to bolster domestic pharmaceutical production, backed by over $30 billion from industry giants like Novartis and Eli Lilly. Yet, drug shortages, especially in sterile injectables, continue to plague the system, exacerbated by dependence on single suppliers and foreign ingredients. Tariffs threaten to deepen this crisis, underscoring the urgent need for effective solutions.